Heparin-induced thrombocytopenia secondary prevention: Difference between revisions
Gerald Chi- (talk | contribs) (Created page with "__NOTOC__ {{Heparin-induced thrombocytopenia}} {{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}}, Aric C. Hall, M.D., [mailto:achall@bidmc.harvard.edu] ==Overview== ==Second...") |
m (Categories) |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Heparin-induced thrombocytopenia}} | {{Heparin-induced thrombocytopenia}} | ||
{{CMG}}; | {{CMG}}; | ||
==Overview== | ==Overview== | ||
| Line 8: | Line 8: | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
==Reference== | |||
{{Reflist|2}} | |||
[[Category:Hematology]] | |||
{{WS}} | |||
{{WH}} | |||
Revision as of 19:45, 17 June 2016
|
Heparin-induced thrombocytopenia |
|
Differentiating Heparin-induced thrombocytopenia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Heparin-induced thrombocytopenia secondary prevention On the Web |
|
American Roentgen Ray Society Images of Heparin-induced thrombocytopenia secondary prevention |
|
FDA on Heparin-induced thrombocytopenia secondary prevention |
|
CDC on Heparin-induced thrombocytopenia secondary prevention |
|
Heparin-induced thrombocytopenia secondary prevention in the news |
|
Blogs on Heparin-induced thrombocytopenia secondary prevention |
|
Directions to Hospitals Treating Heparin-induced thrombocytopenia |
|
Risk calculators and risk factors for Heparin-induced thrombocytopenia secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];